Mabtas T 500 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Mabtas T 500 mg Injection

Mabtas T 500 mg Injection

Mabtas T 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune conditions. It is commonly used for non-Hodgkin lymphoma and chronic lymphocytic leukemia, and may also be prescribed for specific autoimmune disorders. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Rituximab works by targeting the CD20 protein present on certain B-cells, helping the immune system destroy these abnormal or overactive cells. It may be used alone or with other medicines depending on the condition and prescribed treatment protocol. Patients require monitoring during and after infusion because infusion-related reactions and infections can occur. The treatment schedule and dose are determined by the specialist according to the disease, clinical response, and individual patient factors.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 50 mL, 1 Vial

Product Also Known As

Mabtas T 500mg Injection, Mabtas T 500 mg Injection, Mabtas T 500mg Vial, Rituximab 500mg Injection, Rituximab 500 mg Injection, Rituximab 500mg Infusion, Rituximab 50mg/mL Injection